Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis.
about
Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Letter: a prospective real lif ...... to severe ulcerative colitis.
@en
Letter: a prospective real lif ...... to severe ulcerative colitis.
@nl
type
label
Letter: a prospective real lif ...... to severe ulcerative colitis.
@en
Letter: a prospective real lif ...... to severe ulcerative colitis.
@nl
prefLabel
Letter: a prospective real lif ...... to severe ulcerative colitis.
@en
Letter: a prospective real lif ...... to severe ulcerative colitis.
@nl
P2093
P2860
P356
P1476
Letter: a prospective real lif ...... e to severe ulcerative colitis
@en
P2093
C Sapienza
M Affronti
P2860
P304
P356
10.1111/APT.13692
P407
P577
2016-08-01T00:00:00Z